Display options
Cite
Qayyum A, Oei EL, Paudel K, et al. Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions. World J Nephrol. 2015;4(1):92-7doi: 10.5527/wjn.v4.i1.92.
Qayyum, A., Oei, E. L., Paudel, K., & Fan, S. L. (2015). Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions. World journal of nephrology, 4(1), 92-7. https://doi.org/10.5527/wjn.v4.i1.92
Qayyum, Ahad, et al. "Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions." World journal of nephrology vol. 4,1 (2015): 92-7. doi: https://doi.org/10.5527/wjn.v4.i1.92
Qayyum A, Oei EL, Paudel K, Fan SL. Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions. World J Nephrol. 2015 Feb 06;4(1):92-7. doi: 10.5527/wjn.v4.i1.92. PMID: 25664250; PMCID: PMC4317632.
Copy Download .nbib Format: NLM
Share it on

World J Nephrol. 2015 Feb 06;4(1):92-7. doi: 10.5527/wjn.v4.i1.92.

Increasing the use of biocompatible, glucose-free peritoneal dialysis solutions.

World journal of nephrology

Ahad Qayyum, Elizabeth Ley Oei, Klara Paudel, Stanley L Fan

Affiliations

  1. Ahad Qayyum, Klara Paudel, Stanley L Fan, Department of Renal Medicine and Transplantation, The Royal London Hospital, Barts Health NHS Trust, London E1 1BB, United Kingdom.

PMID: 25664250 PMCID: PMC4317632 DOI: 10.5527/wjn.v4.i1.92

Abstract

A major concern inhibiting some clinicians from embracing peritoneal dialysis (PD) as the preferred first modality of dialysis is the effects of PD solutions on the peritoneal membrane. These anatomical and functional changes predispose to complications like peritonitis, encapsulating peritoneal sclerosis and ultrafiltration failure. In recent years, "biocompatible" and glucose-sparing PD regimens have been developed to minimize damage to the peritoneal membrane. Can the use of these more expensive solutions be justified on current evidence? In this review of the literature, we explore how we may individualize the prescription of biocompatible PD fluid.

Keywords: Biocompatibility; Glucose degradation products; Individualized prescription; Peritoneal dialysis; Peritonitis; Residual renal function; Ultrafiltration failure

References

  1. Am J Kidney Dis. 2001 Jan;37(1 Suppl 2):S103-7 - PubMed
  2. Kidney Int. 1998 Nov;54(5):1731-8 - PubMed
  3. Kidney Int. 1995 Apr;47(4):1148-57 - PubMed
  4. Nephrol Dial Transplant. 2001;16 Suppl 5:61-6 - PubMed
  5. J Am Soc Nephrol. 2009 Jan;20(1):155-63 - PubMed
  6. Perit Dial Int. 2005 Feb;25 Suppl 3:S64-8 - PubMed
  7. Artif Organs. 1978 Feb;2(1):84-6 - PubMed
  8. Nephrol Dial Transplant. 2004 Oct;19(10):2584-91 - PubMed
  9. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S57-60 - PubMed
  10. Nephrol Dial Transplant. 1996 Mar;11(3):498-506 - PubMed
  11. J Am Soc Nephrol. 2013 Nov;24(11):1889-900 - PubMed
  12. J Am Soc Nephrol. 2005 Feb;16(2):546-54 - PubMed
  13. Diabetes. 2014 May;63(5):1738-47 - PubMed
  14. J Am Soc Nephrol. 2001 May;12(5):1046-51 - PubMed
  15. J Am Soc Nephrol. 2002 Feb;13(2):470-9 - PubMed
  16. Kidney Int. 2003 Apr;63(4):1556-63 - PubMed
  17. Nephrol Dial Transplant. 2009 Oct;24(10):3209-15 - PubMed
  18. Kidney Int Suppl. 2003 Dec;(88):S43-9 - PubMed
  19. Perit Dial Int. 2000;20 Suppl 5:S57-67 - PubMed
  20. Kidney Int. 1998 Apr;53(4):1061-7 - PubMed
  21. Nephrol Dial Transplant. 1995;10(1):64-9 - PubMed
  22. Perit Dial Int. 2009 Nov-Dec;29(6):647-55 - PubMed
  23. Clin Nephrol. 2002 Dec;58(6):445-50 - PubMed
  24. J Am Soc Nephrol. 2012 Jun;23(6):1097-107 - PubMed
  25. Perit Dial Int. 1997 Jan-Feb;17(1):27-34 - PubMed
  26. J Ren Care. 2006 Oct-Dec;32(4):198-201 - PubMed

Publication Types